In the present study, we speculated that TMZ could enhance myocardial cell Na+-K+ ATPase activity and maintain K+ homeostasis to ensure the supply and delivery of ATP in an HF mouse model and increase the expression of ATP1α1 to protect the structure and function of mitochondria, thus improving heart energy metabolism to treat HF. The gene discussed is ATP1A1; the disease is hydrops fetalis.